Cargando…
Treatment of diabetic kidney disease: current and future targets
Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease in Korea and worldwide, and is a risk factor for the development of cardiovascular complications. The conventional treatments for DKD are control of blood glucose and blood pressure levels by inhibiting the renin-angiotensin...
Autor principal: | Kim, Mi-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511942/ https://www.ncbi.nlm.nih.gov/pubmed/28704915 http://dx.doi.org/10.3904/kjim.2016.219 |
Ejemplares similares
-
Treatment of Diabetic Kidney Disease: Current and Future
por: Yamazaki, Tomotaka, et al.
Publicado: (2021) -
Present and Future in the Treatment of Diabetic Kidney Disease
por: Quiroga, Borja, et al.
Publicado: (2015) -
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
por: Yu, Ji Hee, et al.
Publicado: (2022) -
Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions
por: Lee, Dae-Won, et al.
Publicado: (2016) -
Obesity-Related Kidney Disease: Current Understanding and Future Perspectives
por: Kreiner, Frederik F., et al.
Publicado: (2023)